2-anthramine has been researched along with 4-ipomeanol in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boyd, MR; Langenbach, R; Nesnow, S; Philpot, RM; Smith, PB; Tiano, HF | 1 |
Breakefield, XO; Chiocca, EA; Dobberstein, KU; Herrlinger, U; Hilton, J; Kramm, CM; Philpot, RM; Rainov, NG; Sena-Esteves, M | 1 |
Fischer, U; Frank, S; Kramm, CM; Rainov, NG; Steffens, S; Tlolko, A | 1 |
3 other study(ies) available for 2-anthramine and 4-ipomeanol
Article | Year |
---|---|
4-Ipomeanol and 2-aminoanthracene cytotoxicity in C3H/10T1/2 cells expressing rabbit cytochrome P450 4B1.
Topics: Amines; Animals; Anthracenes; Antineoplastic Agents; Aryl Hydrocarbon Hydroxylases; Biotransformation; Carcinogens; Cytochrome P-450 Enzyme System; DNA, Complementary; Furans; Immunoblotting; Isoenzymes; Lung; Mice; Mice, Inbred C3H; Rabbits; Terpenes; Transfection | 1995 |
New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol.
Topics: Animals; Anthracenes; Antineoplastic Agents; Apoptosis; Aryl Hydrocarbon Hydroxylases; Blotting, Western; Brain Neoplasms; Culture Media, Conditioned; Cytochrome P-450 Enzyme System; DNA Damage; DNA Fragmentation; DNA, Neoplasm; Genetic Therapy; Glioblastoma; Gliosarcoma; Glutathione; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Plasmids; Prodrugs; Rabbits; Rats; Terpenes; Transfection; Tumor Cells, Cultured | 1998 |
Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: implications for pharmacogene therapy.
Topics: Animals; Anthracenes; Antiviral Agents; Aryl Hydrocarbon Hydroxylases; Blotting, Western; Bystander Effect; Cell Cycle; Cell Survival; Cytochrome P-450 Enzyme System; Flow Cytometry; Ganciclovir; Genetic Therapy; Gliosarcoma; Green Fluorescent Proteins; Herpesvirus 1, Human; Humans; Luminescent Proteins; Pharmacogenetics; Prodrugs; Rabbits; Terpenes; Thymidine Kinase; Transfection; Tumor Cells, Cultured | 2002 |